The Biopharma Pod

Podcast: The British start-up taking psychedelic therapy mainstream

What kind of consistency can industry expect from the FDA post pandemic?

Chicago emerging as a life science and biopharma hub

Will Biden backed bills boost biosimilars uptake in the US?

Bioproduction bottlenecks increasing due to staff shortages, says report

'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI

Better single-use cross flow techs still needed says GE Healthcare

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

The single-use age has dawned, says ThermoFisher

European CMO market will double in just 6 years, says Frost & Sullivan

Acuros in talks with Big Pharma over water-powered delivery pump

Unilife launches Autoinfuser range publically

EMD Millipore talks integration: of processes; and with owner Merck KGaA

OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009

Gene therapy to drive viral and biologics market, says SAFC

BIO 2009: snapshot of an evolving biotech industry